| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 2 |
| NetGPI | no | yes: 0, no: 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9ACB5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.549 |
| DEG_APCC_DBOX_1 | 3 | 11 | PF00400 | 0.650 |
| DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.665 |
| DOC_CYCLIN_yCln2_LP_2 | 15 | 21 | PF00134 | 0.549 |
| DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.549 |
| LIG_EH1_1 | 7 | 15 | PF00400 | 0.521 |
| LIG_eIF4E_1 | 8 | 14 | PF01652 | 0.410 |
| LIG_IRF3_LxIS_1 | 18 | 24 | PF10401 | 0.552 |
| LIG_NRBOX | 10 | 16 | PF00104 | 0.508 |
| LIG_NRBOX | 43 | 49 | PF00104 | 0.549 |
| LIG_Pex14_2 | 22 | 26 | PF04695 | 0.449 |
| LIG_SUMO_SIM_par_1 | 11 | 17 | PF11976 | 0.549 |
| LIG_TYR_ITIM | 6 | 11 | PF00017 | 0.410 |
| LIG_WRC_WIRS_1 | 27 | 32 | PF05994 | 0.446 |
| MOD_CK1_1 | 29 | 35 | PF00069 | 0.451 |
| MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.405 |
| MOD_NEK2_1 | 21 | 26 | PF00069 | 0.470 |
| MOD_NEK2_1 | 34 | 39 | PF00069 | 0.381 |
| MOD_NEK2_1 | 49 | 54 | PF00069 | 0.655 |
| MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.549 |
| TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.410 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| E9AJK3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 93% |